Predictive and prognostic impact of tumour-infiltrating lymphocytes in triple-negative breast cancer treated with neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

Predictive and prognostic impact of tumour-infiltrating lymphocytes in triple-negative breast cancer treated with neoadjuvant chemotherapy

Published:2017-08-15 Issue: Volume:11 Page:
ISSN:1754-6605
Container-title:ecancermedicalscience
language:
Short-container-title:ecancer

Author:

Herrero-Vicent Carmen,Guerrera Angel,Gavilá Joaquin,Gozalbo Francisco,Hernandez Abraham,Sandiego Sergio,Algarra Maria Asunción,Calatrava Ana,Guillem-Porta Vicente,Ruiz-Simón Amparo

Publisher

Ecancer Global Foundation

Subject

Cancer Research,Oncology

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of tumor-infiltrating lymphocytes with clinical outcomes in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy: a systematic review and meta-analysis;Clinical and Translational Oncology;2024-08-18

2. Predictive value of tumor-infiltrating lymphocytes for neoadjuvant therapy response in triple-negative breast cancer: A systematic review and meta-analysis;World Journal of Clinical Oncology;2024-07-24

3. Effect of tumor-infiltrating immune cells (mast cells, neutrophils and lymphocytes) on neoadjuvant chemotherapy response in breast carcinomas;Annals of Diagnostic Pathology;2024-06

4. Implications of tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer: clinical oncologist perspectives;Translational Breast Cancer Research;2024-01

5. Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients;Journal of Experimental & Clinical Cancer Research;2023-11-14